Triples Seasonal Supply from Strategic Moroccan Producer

VANCOUVER, BC and BREDA, NETHERLANDS / ACCESSWIRE / November 25, 2020 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF)(FSE:OGF) ("Organto" or "the Company"), an integrated provider of organic and value-added organic fruits and vegetables today announced that it has contracted for increased seasonal supply of organic avocado from its strategic grower based in Morocco, with a target of tripling supply versus the previous growing season. The first shipment of the season from Morocco is expected to land in Europe this week, with avocados from this source expected to continue through late February to mid-March 2021 depending on growing conditions and product quality.

Organto first entered into a strategic supply relationship with this growing Moroccan supplier in late 2019 and commercial distribution began in January 2020. The product was well received in the markets, and as a result, Organto has arranged to expand its supply from this important supplier and growing region in order to benefit from increasing market demand. Morocco's close proximity to Europe enables Organto to deliver and sell these avocados in European markets approximately one week following harvesting and processing, much faster than the three to five weeks for avocados sourced from Latin American and other African growers, and with a lower carbon footprint.

Organto's year-round avocado supply chain includes supply from strategic sources in Morocco, Colombia, Peru, Mexico, South Africa, Tanzania and Kenya. The Company is continually working to develop new sources of supply in order to meet continued demand from its growing customer base located throughout Europe.

"Demand for avocado continues to grow globally, driven by its nutrient dense nutritional profile and consumer focus on health and wellness. In fact, avocado has been described as the millennial generation's favorite fruit, leading the strong global demand for this product." commented Rients van der Wal, Co-CEO of Organto and CEO of Organto Europe B.V. "We are pleased to expand our sourcing and supply from this important growing region and are fortunate to be teamed with an expanding and progressive strategic supply partner. We view avocado as a key product in our core organic vegetable and fruits portfolio, supported by a year-round supply chain that we have built with strategic supply partners from all around the globe."

Organto expects to realize record fourth quarter revenues of approximately 4.4 to $4.6 million (November 19, 2020 news release), which will be the largest quarterly revenues in the history of the Company, and an increase of approximately 185% versus the same quarter in the prior year. The commercial expansion of organic avocado is expected to be a key contributor to this growth. These results are expected to represent the sixth consecutive quarter of record quarterly revenues for Organto.

ON BEHALF OF THE BOARD,

Steve Bromley
Chair and Co-Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
604-634-0970
1-888-818-1364
info@organto.com

ABOUT ORGANTO

Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders. Organto is an integrated provider of private label and bulk distributed organic and non-GMO fruit and vegetable products using an asset-light business model to serve a growing socially responsible and health conscious consumer around the globe.

FORWARD LOOKING STATEMENTS

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's belief that it will triple supply this growing season from their strategic Moroccan grower and the first shipment will be received the week of this news release; Organto's belief that demand for fresh organic avocado will continue to grow globally; Organto's belief that it is teamed with an expanding and progressive organic avocado supply partner; Organto's belief that it will realize Q-4 revenues of $4.4 to $4.6 million and organic avocado will be a key contributor to this growth; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.

SOURCE: Organto Foods Inc.

ReleaseID: 618307

BROOKLYN, NY / ACCESSWIRE / November 25, 2020 / ZP Realty Capital LLC, also known as Zev Pollak Co. LLC, is proud to announce that it has recently arranged financing for two properties on Ave T in Brooklyn, New York.

ZP Realty Capital LLC. ZP Realty is a privately-held real estate company with a long history of negotiating favorable financing for properties located throughout New York City.

ZP Realty Capital LLC has recently arranged a new mortgage package in the amount of $16,700,000 for a refinance of two six-storey elevator apartment buildings, containing 128 units in total. The mortgage is for a 10-year term at a rate of 2.99%, and 30 years of amortization

"I am very proud of my hard-working team in getting this deal closed during this difficult time," says Pollak.

In 2020, ZP Realty Capital LLC has successfully negotiated a number of mortgages and has been able to continue to provide good financing options for properties despite the COVID-19 pandemic.

Contact:

Zev Pollack
ZP Realty Capital LLC
1388 East 15th Street, Brooklyn, N.Y. 11230
T: 718.339.0500
F: 718.339.0575
info@zpcompany.com

SOURCE: Zev Pollak

ReleaseID: 618350

Market players in the asthma treatment market are focusing on research & development activities for the development of advanced therapeutics to develop an extensive product portfolio.

ROCKVILLE, MD / ACCESSWIRE / November 25, 2020 / The global asthma treatment market is projected to expand at a steady CAGR of 2.3% over the assessment period of 2020-2027. The hospital pharmacies with huge drug inventories are likely to remain a vital distribution channel in the global market, as it becomes convenient for patients to buy drugs straightaway after diagnosis.

"Growing usage of online shopping channels providing same-day / next-day delivery attributes and striking deals will boost sales via online pharmacies. The inclination towards ordering medications via online pharmacies will gain more prominence towards 2027 end." says the Fact.MR report.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=4422

Asthma Treatment Market- Key Takeaways

The global asthma treatment market to reach a market valuation of US$ 10 Bn by 2027 end.
North America is projected to remain dominant in the market capturing the highest market share over the forecast period.
Long-term asthma control medications to gain traction in the global market as compared to quick-relief medications.
Inhaled route of administration segment has foreseen a significant uptick in the global market.
Sales through online pharmacies are expected to skyrocket in the approaching years.

Asthma Treatment Market – Driving Factors

Growing awareness regarding the asthmatic condition and its timely diagnosis is enhancing the demand prospects of the market.
Hospital pharmacies are anticipated to catalyze sales of asthma treatment over the forecast period.
Rising demand for better health facilities and innovation in biological drugs are projected to propel the market growth.

Asthma Treatment Market – Constraints

High prices associated with asthma inhalers along with easy availability of generic drugs can limit the adoption of the asthma treatment market.
Rising popularity of alternative treatments can challenge the market growth.

Anticipated Market Impact by COVID-19 Outbreak

The COVID-19 pandemic has brought the world to a halt. Several businesses have been impacted by the crisis across industries. However, the asthma treatment market is anticipated to be positively impacted by the initial hiccup amid the crisis. The growing threat of death in asthma patients during the crisis is anticipated to fuel the need for pre-diagnosis, which, consecutively, will assist the market growth.

Explore the global Asthma Treatment market with 102 figures, 39 data tables, along with the table of contents of the report. You can also find detailed segmentation on https://www.factmr.com/report/4422/asthma-treatment-market

Competition Landscape

Key market players in the asthma treatment market are Teva Pharmaceutical Industries, Mylan N.V., AstraZeneca PLC., Boehringer Ingelheim, Sunovion Pharmaceutical, Inc., Sanofi, Novartis International AG, F.Hoffmann-La Roche Ltd., Merck & Co., Inc. and GlaxoSmithKline PLC. Incessant presentation of new therapeutics is fortifying portfolios of the key players as well as a well-established brand identity of prominent players further boost their sales forecasts.

More on the Report

The Fact.MR's market research report provides in-depth insights into the asthma treatment market. The market is scrutinized based on treatment type (long-term asthma control medications and quick-relief (rescue) medications), route of administration (inhaled, oral, intravenous, and subcutaneous), and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across five major regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA)).

Explore Wide-ranging Coverage of Fact.MR's Healthcare Landscape

Asthma Spacers Market: Find insights on the Asthma Spacers market with analysis of segments, statistics, influencers, market players, and business strategies adopted over a 10-year forecast period.

Diverticular Disease Therapeutics Market: Fact.MR's report on the diverticular disease therapeutics market offers insights on the market during 2018-2028, including restraints, revenue sources, market leaders, and market strategies.

Tumour-Induced Osteomalacia Market: Read an analysis of the tumour-induced osteomalacia market with insights on growth factors, opportunities, restraints, regional market forecast, regulatory policies, and strengths of market leaders.

About Fact.MR

Fact.MR is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Fact.MR is headquartered in Dublin, and has offices in Dubai. Fact.MR's latest market research reports industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition.

Contact:

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
PR- https://www.factmr.com/media-release/1207/asthma-treatment-demand

SOURCE: FactMR

ReleaseID: 618349

BISHOPSGATE, LONDON / ACCESSWIRE / November 25, 2020 / SolGold plc (TSX:SOLG) ("SolGold" or the "Company") Due to SolGold's focus on active shareholder engagement and as a result of a number of inbound enquiries regarding the upcoming Annual General Meeting ("AGM"), to be convened on 17 December 2020, the Company has requested that its proxy advisers send written instructions to shareholders advising them of the voting process.

A generalised copy of that letter is written below for the use and information of all registered shareholders. Please contact the Company's proxy advisers, CMi2i, directly for further information.

The Board of SolGold encourages all eligible shareholders to cast their votes for the AGM in advance of the proxy cut-off time (15 December 2020).

The SolGold AGM will be held virtually via Lumi due to the ongoing restrictions relating to the Covid-19 pandemic. Information on how to login and access the meeting is included in the Management Information Circular on the SolGold website for those shareholders who wish to participate in the meeting electronically.

By order of the Board

Karl Schlobohm
Company Secretary

Dear SolGold Shareholder,

I am writing to you on behalf of the Board with respect to the Company's forthcoming Annual General Meeting and the resolutions the Company is seeking approval for therein. The Annual General Meeting will be convened virtually via Lumi, on 17 December 2020 at 9:00pm (Brisbane, Australia time), 11:00am (London time), 6:00 am (Toronto time).

It is very important that all shareholders vote to support the Board's recommendations in respect of all the resolutions. Voting for all resolutions will maintain SolGold‘s outstanding business strategy to deliver substantial value to all shareholders.

There is no guarantee that the resolutions will pass without your support and it is important that you support the re-election of Directors and the financing resolutions which will enable SolGold to:

Continue to advance the Alpala project towards feasibility;
Continue to deliver exploration results, and new discoveries; and
Deliver value adding conditional multi-source financing proposals and to continue to promote the Company's strategies in Ecuador to shareholders and to capital markets broadly.

The Board has made significant advancements in increasing skills, gender diversity and independence on the SolGold Board, including the appointment of Mrs Elodie Grant Goodie, Kevin O'Kane, Keith Marshall and Mrs Maria Amparo in recent months. The Board intends to continue to work towards compliance with the UK Corporate Governance Code, accommodate shareholder representation and maintain the valuable intellectual property around geology and exploration activities, social operations in Ecuador, government liaison and project financing, which have all been built at Board level to date.

In order to maintain the skills and experience at Board level, it is critical that you vote for the re-election of all Directors.

Succession Planning

As part of the evolution of SolGold from explorer only to explorer and developer, the Company will continue to add to the skill base of the Executive and Senior Management team around mine feasibility studies, development planning financing and in time, operations. Key appointments are expected to be made in the critical areas of block caving expertise, mine construction, metallurgy, tailings management and development financing in the near future.

The Board intends to ensure that it has the expertise and experience to support the Company and its projects and to that end, it will actively monitor that it has available to it the necessary skills to advance the interests of the Company for all shareholders.

Business Strategy

SolGold will continue to pursue customised objectives for the development of the Company's world-class asset portfolio. Re-election of all the Directors is critical to the maintenance of SolGold's independence. Mr Mather's personal interest in and investment in SolGold ensures his personal alignment with all shareholder interests.

SolGold will focus on:

The Alpala Pre-Feasibility and Feasibility programs, which will continue to be driven by the SolGold management team and Board and overseen by the recently constituted and announced Alpala Project Committee, which is a specialised and independently dominated subcommittee of the SolGold Board and Management team with a specific charter to overview the completion of the studies on a best practice basis. Your vote to return the Directors will support the continuation of this independent practice.

Exploration for and discovery of world-class copper-gold porphyry deposits across its 14 major project areas throughout the length of Ecuador plus additional targets covered by currently ungranted tenure over these targets. The Company will continue to execute on its regional exploration program, including a US$40 million exploration budget for the next 12 months. Additional funding will be raised for more intense programs to define resources in the case of discoveries made during the regional program. SolGold's strategy of building an integrated pipeline of exploration projects developments and mines in Ecuador will lay the foundation for creation of a globally important copper gold producer in the future. Mr Jason Ward will continue to head the SolGold's regional programs and social strategies in Ecuador generally.

Conditional project development funding activities, which will continue to be pursued by SolGold's Board and management headed by Mr Ingo Hofmaier, with a view to obtaining the best independent multi-source financing package for the Alpala project. SolGold's advisor Citi, will continue to ensure that best practice is applied to available financing options for Alpala. Again, re-election of the current Directors is critical to ensuring that a broad range of independent financing options are canvassed and progressed with a view to securing the best terms for all shareholders.

Please urgently instruct your Private Client Broker directly to vote on your behalf in support of resolutions 1 through 12, which will be proposed as Ordinary Resolutions, and Resolutions 13 to 15, which will be proposed as Special Resolutions.

Ordinary Resolutions:

Annual Report
Remuneration Report
Re-elect Mr. Nicholas Mather
Re-elect Mr. James Clare
Elect Ms. Elodie Grant Goodey
Elect Mr. Kevin O'Kane
Elect Mrs. Maria Amparo Alban
Elect Mr. Keith Marshall
Re-appoint BDO (UK) LLP as auditors
Determination of remuneration of Auditors
Authorise the Company to allot shares
Increase in the limit on Directors' Fees

Special Resolutions:

Disapplication of Pre-Emption Rights of Existing Shareholders
Further Disapplication of Pre-Emption Rights of Existing Shareholders
Shorter Notice Period for Calling General Meetings

The Board unanimously recommends that shareholders vote in favour of all resolutions, as they intend to do so in respect of their own shareholdings.

Instructions

In order to follow the Directors' recommendations at the forthcoming AGM, please contact your broker (or other registered holder) directly and instruct them how to vote on your behalf.

The voting deadline is 11:00 a.m. (London time) on 15 December 2020, but your Private Client Broker will have an earlier deadline. It is best to instruct them as soon as possible.

There is also the option to vote electronically during the virtual meeting on 17 December, 2020. Please head to https://www.solgold.com.au/notice-of-meetings/ for more information on how to access the online Lumi system.

Clients of AJ Bell

In order to follow recommendations at the forthcoming AGM and vote, please:

Contact your broker, AJ Bell Securities/Lawshare Nominees, directly on 0345 37 33 479 (if calling from within the UK) and instruct them of your vote as soon as possible and by no later than 8 December 2020; or
Elect online by signing up or logging on to https://www.youinvest.co.uk/securelogin or https://www.sippcentre.co.uk/Login/Username/ and casting your vote by 8 December 2020.

Clients of Interactive Investor

In order to follow recommendations at the forthcoming AGM and vote, please:

Contact your broker, Interactive Investor, directly on 0345 607 6001 (if calling from within the UK) or +44 (0)113 346 2309 (if calling from outside the UK) and instruct them of your vote as soon as possible and by no later than 8 December 2020; or
Vote by signing up or logging on to https://secure.ii.co.uk/webbroker2/login.jsp and making your elections. For more information on Interactive Investor's election procedures, please visit http://www.iii.co.uk/shareholder-voting-and-information and cast your vote by 8 December 2020.

Clients of Halifax Share Dealing / HSDL Nominees

In order to follow recommendations at the forthcoming AGM and vote, please:

Contact your broker, Halifax Share Dealing/HSDL Nominees, directly on 03457 22 55 25 (if calling from within the UK) and instruct them of your vote as soon as possible and by no later than 8 December 2020; or
Elect online by signing up or logging on to the Halifax Share Dealing website at https://www.halifax.co.uk/sharedealing and selecting ‘Account Management' and then ‘Important Notifications'. Halifax Share Dealing should forward you notifications for all companies where you hold stock as and when they are received.

Clients of Hargreaves Lansdown

In order to follow recommendations at the forthcoming AGM and vote, please:

Contact your broker, Hargreaves Lansdown and instruct them of your vote as soon as possible and by no later than 10 December 2020; or

Elect online by signing up or logging on to your account on the Hargreaves Lansdown website at www.hl.co.uk and then send a secure message to instruct them of your vote by 10 December 2020.

General Assistance

A copy of the Meeting Notice and other information required by Section 311A of the Act can be found at https://www.solgold.com.au/notice-of-meetings/

If you have any questions or queries, please feel free to contact myself, Liam Twigger, or CEO Nick Mather on +61 7 3303 0660.

CMi2i are the official Information Agent to SolGold plc. Should you have any questions regarding the voting process, please contact CMi2i on 0800 029 4356 or + 44 (0) 20 8187 1429. Alternatively, you may e-mail your enquiries to solgold@cmi2i.com

CONTACTS

Nicholas Mather

SolGold Plc (Chief Executive Officer) nmather@solgold.com.au

Tel: +61 (0) 7 3303 0665

Karl Schlobohm

SolGold Plc (Company Secretary)

kschlobohm@solgold.com.au

Tel: +61 (0) 7 3303 0661

Ingo Hofmaier

SolGold Plc (GM – Project & Corporate Finance) ihofmaier@solgold.com.au

Tel: +44 (0) 20 3823 2131

Gordon Poole / Nick Hennis

Camarco (Financial PR / IR)

solgold@camarco.co.uk

Tel: +44 (0) 20 3757 4997

Andrew Chubb

Hannam & Partners (Joint Broker and Financial Advisor)

solgold@hannam.partners

Tel: +44 (0) 20 7907 8500

Ross Allister / David McKeown

Peel Hunt (Joint Broker and Financial Advisor)

solgold@peelhunt.com

Tel: +44 (0)20 7418 8900

James Kofman / Darren Wallace

Cormark Securities Inc. (Financial Advisor)

dwallace@cormark.com

Tel: +1 416 943 6411

Clayton Bush / Scott Mathieson

Liberum (Joint Broker and Financial Advisor)

Clayton.Bush@liberum.com

Tel: +44 (0) 20 3100 2184

Follow us on twitter @SolGold_plc

ABOUT SOLGOLD

SolGold is a leading resources company focussed on the discovery, definition and development of world-class copper and gold deposits. In 2018, SolGold's management team was recognised by the "Mines and Money" Forum as an example of excellence in the industry and continues to strive to deliver objectives efficiently and in the interests of shareholders. SolGold is the largest and most active concession holder in Ecuador and is aggressively exploring the length and breadth of this highly prospective and gold-rich section of the Andean Copper Belt.

The Company operates with transparency and in accordance with international best practices. SolGold is committed to delivering value to its shareholders, while simultaneously providing economic and social benefits to impacted communities, fostering a healthy and safe workplace and minimizing the environmental impact.

Dedicated stakeholders

SolGold employs a staff of over 700 employees of whom 98% are Ecuadorean. This is expected to grow as the operations expand at Alpala, and in Ecuador generally. SolGold focusses its operations to be safe, reliable and environmentally responsible and maintains close relationships with its local communities. SolGold has engaged an increasingly skilled, refined and experienced team of geoscientists using state of the art geophysical and geochemical modelling applied to an extensive database to enable the delivery of ore grade intersections from nearly every drill hole at Alpala. SolGold has over 80 geologists on the ground in Ecuador exploring for economic copper and gold deposits.

About Cascabel and Alpala

The Alpala deposit is the main target in the Cascabel concession, located on the northern section of the heavily endowed Andean Copper Belt, the entirety of which is renowned as the base for nearly half of the world's copper production. The project area hosts mineralisation of Eocene age, the same age as numerous Tier 1 deposits along the Andean Copper Belt in Chile and Peru to the south. The project base is located at Rocafuerte within the Cascabel concession in northern Ecuador, an approximately three-hour drive on sealed highway north of the capital Quito, close to water, power supply and Pacific ports.

Having fulfilled its earn-in requirements, SolGold is a registered shareholder with an unencumbered legal and beneficial 85% interest in ENSA (Exploraciones Novomining S.A.) which holds 100% of the Cascabel concession covering approximately 50km2. The junior equity owner in ENSA is required to repay 15% of costs since SolGold's earn in was completed, from 90% of its share of distribution of earnings or dividends from ENSA or the Cascabel concession. It is also required to contribute to development or be diluted, and if its interest falls below 10%, it shall reduce to a 0.5% NSR royalty which SolGold may acquire for US$3.5million.

Advancing Alpala towards development

The resource at the Alpala deposit contains a high-grade core which will be targeted to facilitate early cashflows and an accelerated payback of initial capital. SolGold is currently progressing its Pre-Feasibility Study and is fully funded through to development decision following the Net Smelter Royalty Financing with Franco-Nevada Corporation for US$100million. Franco-Nevada will receive a perpetual 1% NSR interest from the Cascabel licence area.

SolGold is currently assessing financing options available to the Company for the development of the Alpala mine following completion of the Definitive Feasibility Study.

SolGold's Regional Exploration Drive

SolGold is using its successful and cost-efficient blueprint established at Alpala, and Cascabel generally, to explore for additional world class copper and gold projects across Ecuador. SolGold is the largest and most active concessionaire in Ecuador.

The Company wholly owns four other subsidiaries active throughout the country that are now focussed on thirteen high priority gold and copper resource targets, several of which the Company believes have the potential, subject to resource definition and feasibility, to be developed in close succession or even on a more accelerated basis compared to Alpala.

SolGold is listed on the London Stock Exchange and Toronto Stock Exchange (LSE/TSX: SOLG). The Company has on issue a total of 2,072,213,494 fully-paid ordinary shares and 113,175,000 share options.

Quality Assurance / Quality Control on Sample Collection, Security and Assaying

SolGold operates according to its rigorous Quality Assurance and Quality Control (QA/QC) protocol, which is consistent with industry best practices.

Primary sample collection involves secure transport from SolGold's concessions in Ecuador, to the ALS certified sample preparation facility in Quito, Ecuador. Samples are then air freighted from Quito to the ALS certified laboratory in Lima, Peru where the assaying of drill core, channel samples, rock chips and soil samples is undertaken. SolGold utilises ALS certified laboratories in Canada and Australia for the analysis of metallurgical samples.

Samples are prepared and analysed using 100g 4-Acid digest ICP with MS finish for 48 elements on a 0.25g aliquot (ME-MS61). Laboratory performance is routinely monitored using umpire assays, check batches and inter-laboratory comparisons between ALS certified laboratory in Lima and the ACME certified laboratory in Cuenca, Ecuador.

In order to monitor the ongoing quality of its analytical database, SolGold's QA/QC protocol encompasses standard sampling methodologies, including the insertion of certified powder blanks, coarse chip blanks, standards, pulp duplicates and field duplicates. The blanks and standards are Certified Reference Materials supplied by Ore Research and Exploration, Australia.

SolGold's QA/QC protocol also monitors the ongoing quality of its analytical database. The Company's protocol involves Independent data validation of the digital analytical database including search for sample overlaps, duplicate or absent samples as well as anomalous assay and survey results. These are routinely performed ahead of Mineral Resource Estimates and Feasibility Studies. No material QA/QC issues have been identified with respect to sample collection, security and assaying.

Reviews of the sample preparation, chain of custody, data security procedures and assaying methods used by SolGold confirm that they are consistent with industry best practices and all results stated in this announcement have passed SolGold's QA/QC protocol.

The data aggregation method for calculating Copper Equivalent (CuEq) for down-hole drilling intercepts and rock-saw channel sampling intervals are reported using copper equivalent (CuEq) cut-off grades with up to 10m internal dilution, excluding bridging to a single sample and with minimum intersection length of 50m.

Copper Equivalent is currently calculated (assuming 100% recovery of copper and gold) using a Gold Conversion Factor of 0.751 (CuEq = Cu + Au x 0.751), calculated from a current nominal copper price of US$3.30/lb and a gold price of US$1700/oz.

True widths of downhole intersections are not well constrained. Drill hole one was inclined -55degrees towards the east, and the interpreted trend of the Cacharposa Intrusive Complex and its associated porphyry copper-gold mineralisation is subvertical, dipping approximately 85-90 degrees to the west. The true width of down-hole intersections reported are therefore expected to be approximately 55-60% of the down-hole lengths.

See www.solgold.com.au for more information. Follow us on twitter @SolGold plc

CAUTIONARY NOTICE

News releases, presentations and public commentary made by SolGold plc (the "Company") and its Officers may contain certain statements and expressions of belief, expectation or opinion which are forward looking statements, and which relate, inter alia, to interpretations of exploration results to date and the Company's proposed strategy, plans and objectives or to the expectations or intentions of the Company's Directors. Such forward-looking and interpretative statements involve known and unknown risks, uncertainties and other important factors beyond the control of the Company that could cause the actual performance or achievements of the Company to be materially different from such interpretations and forward-looking statements.

Accordingly, the reader should not rely on any interpretations or forward-looking statements; and save as required by the exchange rules of the TSX and LSE or by applicable laws, the Company does not accept any obligation to disseminate any updates or revisions to such interpretations or forward-looking statements. The Company may reinterpret results to date as the status of its assets and projects changes with time expenditure, metals prices and other affecting circumstances.

This release may contain "forward‑looking information" within the meaning of applicable Canadian securities legislation. Forward‑looking information includes, but is not limited to, statements regarding the Company's plans for developing its properties. Generally, forward‑looking information can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved".

Forward‑looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward‑looking information, including but not limited to: transaction risks; general business, economic, competitive, political and social uncertainties; future prices of mineral prices; accidents, labour disputes and shortages and other risks of the mining industry. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, risks relating to the ability of exploration activities (including assay results) to accurately predict mineralization; errors in management's geological modelling; capital and operating costs varying significantly from estimates; the preliminary nature of visual assessments; delays in obtaining or failures to obtain required governmental, environmental or other required approvals; uncertainties relating to the availability and costs of financing needed in the future; changes in equity markets; inflation; the global economic climate; fluctuations in commodity prices; the ability of the Company to complete further exploration activities, including drilling; delays in the development of projects; environmental risks; community and non-governmental actions; other risks involved in the mineral exploration and development industry; the ability of the Company to retain its key management employees and skilled and experienced personnel; and those risks set out in the Company's public documents filed on SEDAR at www.sedar.com. Accordingly, readers should not place undue reliance on forward‑looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

The Company and its officers do not endorse, or reject or otherwise comment on the conclusions, interpretations or views expressed in press articles or third-party analysis, and where possible aims to circulate all available material on its website.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: SolGold PLC

ReleaseID: 618347

TORONTO, ON / ACCESSWIRE / November 25, 2020 / Sparta Group (TSXV:SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta Capital" or "Sparta") has secured two noteworthy orders just weeks after forming its Sparta Health Group division ("Sparta Health"), thus answering the call for immediate help with Personal Protective Equipment ("PPE") due to COVID-19.

With the initial intent to develop a program utilizing proper process control engineering principles to help streamline the purchasing of PPE, Sparta's Healthcare division has also been able to facilitate significant initial orders to supply Canadian health-care facilities with some 10 million pairs of medical-grade gloves. The $2.5 million worth of imported gloves will go a long way in helping protect staff in healthcare facilities in Calgary and Toronto.

"When we set up our PPE purchasing system with Motocitee Industries, we felt we had the right partner and the right processes to give facilities in need a better chance at attaining supplies. And now we can safely say that it really feels good to know that our system is already helping the people who need it the most," said Sparta President and Chief Technology Officer, John O'Bireck.

On November 5th, Sparta announced that it would be expanding its COVID-19 Safety efforts by forming Sparta Health Group Ltd. ("Sparta Health") and partnering with Health Canada approved supplier, Motocitee Industries Inc. Since that time, Sparta has been fielding many inquiries about PPE, including gloves.

The Centers for Disease Control and Prevention ("CDC") reports that in addition to face masks, disposable gloves are an important tool in protecting yourself from COVID-19, especially if you work in the healthcare sector. Unfortunately, much like hand sanitizer being in short supply at the beginning of the pandemic, disposable gloves have become harder for people to find. Due to the formation of the Sparta Health Group those who need PPE the most, such as hospital and long-term care staff, now have easier access to supplies since traditional slow-downs in the purchase-to-delivery process are not a factor.

"Since the formation of Sparta Health, and the collaboration between Motocitee and the Sparta team, it has become very apparent that the strategic partnership is already accelerating the ability to get these PPE products into the hands of people who need them," added Jason Smith, Managing Director of Sparta Health.

As more orders come in, Sparta Health will continue to distribute its previously announced line of pathogen protection formulations. Over the summer Sparta's natural, alcohol free, non-toxic antimicrobial spray was demonstrated at a church in Woodbridge and garnered significant media attention. This after the Company announced it was distributing the protectant to the trucking industry – specifically to safeguard the inside of truck cabs. Since interest is growing, Sparta is looking at expanding its line of environment-safe pathogen protection technologies to provide microbe control in a number of sectors, including offices, medical facilities, and factories.

"Sparta is and always will be an environmental company focused on upcycling waste and optimizing energy. But there are times when companies like ours need to pivot to help the workforce get through difficult times and this is one of those times in our history," said O'Bireck.

About Sparta™

Sparta Group (a.k.a. Sparta Capital Ltd.) is a technology-based company that owns or holds a controlling interest in a network of independent businesses that supply energy saving technologies designed to reduce energy inefficiencies, achieve reduced emissions and increase operating efficiencies in various industries. In response to the COVID-19 crisis, Sparta has also expanded its scope to help facilitate supply of necessary materials while assisting talented inventors who are looking to introduce innovative technical solutions that will bring greater normalcy to the post COVID-19 world. Sparta's network of independent businesses provides a wide range of specialized energy capturing, converting, optimizing, and related services to the commercial sector. Sparta provides capital, technical and engineering expertise, legal support, financial and accounting knowledge, strategic planning and other shared services to its independent businesses.

Sparta is a publicly traded company listed on the TSX Venture Exchange Inc. under the symbol "SAY" (TSX.V: SAY). Additional information is available at www.spartagroup.ca or on SEDAR at www.sedar.com.

For further information please contact:

John O'Bireck, President & CTO
Email: jobireck@spartagroup.ca
Telephone: (905) 751-8004

Cautionary Statements:

This news release contains "forward-looking information" within the meaning of applicable securities laws. When used in this news release, the words "estimate", "project", "belief", "anticipate", "intend", "expect", "plan", "predict", "may" or "should" and the negative of these words or such variations thereon or comparable terminology are intended to identify forward-looking statements and information. Although the Corporation believes in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate that the expectations reflected in this forward-looking information are reasonable, readers are cautioned to not place undue reliance on forward-looking information because the Corporation can give no assurance that they will prove to be correct. Forward-looking statements are made based on management's beliefs, estimates and opinions on the date of publication of this news release and the Corporation undertakes no obligation to update such forward-looking statements if these beliefs, estimates and opinions or other circumstances should change. Furthermore, the Corporation undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Corporation. These include, but are not limited to, the failure to obtain necessary regulatory approvals, necessary financing and risks associated with the environmental technologies industry in general. All forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Sparta Group

ReleaseID: 618330

NOBLESVILLE, IN / ACCESSWIRE / November 25, 2020 / A group of concerned citizens of Noblesville is asking Mayor Chris Jensen to take time to evaluate his suggested alternative route to extend Pleasant Street west over the White River. The Noblesville Bypass Coalition charges that the Mayor's plan would add an unnecessary roundabout and force a major employer out of Noblesville. Their campaign is called "Pick The Right Route."

The Coalition is being led by IDI Composites International, a high tech manufacturer in Noblesville, and its employees who say they will have no choice but to move from their current location on 7th Street where they have been for over 50 years. Mayor Jensen is proposing a new alternative to the Pleasant St. Extension called B1 that adds a second roundabout within 100 yards of the first roundabout at 8th St. and then cuts through IDI's campus. The Coalition supports an extension of Pleasant St. to reduce traffic through downtown Noblesville, but they do not believe the Mayor has taken enough time to evaluate his suggested route to find the best alternative. The B-1 alternative route is intended to go around the newly designated historic neighborhood of Plum Prairie.

"We believe there are better alternatives to what the Mayor is suggesting, but he seems unwilling to listen to his constituents to find the best solution," said Tom Merrell, President and CEO of IDI Composites International. "We value our community and we want to stay in Noblesville. But if Mayor Jensen's plan is approved, we will be forced to move our facility in which we have invested over $15 million since 2012. The Mayor's Pleasant Street Extension design ruins both the functionality of our operations and the desired visual aesthetic we wish to convey to our high-tech, Fortune 500 visitors from around the globe."

IDI Composites International, which began in 1966, employs almost 100 people at its manufacturing, research & development and world headquarters in Noblesville at an average salary of $73,000 plus benefits. The Company has said that it likely would not relocate in Noblesville due to the high cost. IDI has also contributed over $1 million dollars in community and civic projects in recent years.

Members of the Coalition attended a Community Advisory Committee meeting on November 12 where consultants for the City presented its B-1 alternative route. Despite a number of questions and concerns from the audience, the consultants indicated that they had already settled on their suggested route. The Coalition is asking the Mayor to slow down and study the best alternative rather than rush to get the B-1 route approved.

For more information, go to the Coalition's website at www.PickTheRightRoute.com.

Media Contact

Kevin Flynn
(317)213-7799
kflynn@cvrindy.com

SOURCE: Noblesville Bypass Coalition

ReleaseID: 618323

JACKSON CENTER, PA / ACCESSWIRE / November 25, 2020 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO, William A. Hartman, was interviewed this week by host, Donald Baillargeon, on Money TV. Mr. Hartman recapped the company's accomplishments, describing its most promising technologies and described the unique applications perceived, including a sneak peek at the future.

Mr. Hartman detailed some of the most recent developments in Halberd's top priority research: to develop products which should facilitate diagnostic, prevention and treatment of Covid-19. This includes:

Three issued patents;
Six provisional patent applications;
Two unique Covid-19 antibodies;
Nasal spray preventative alternative to Covid-19 vaccine (under development);
Patent-pending fluorescent antibody for rapid Covid-19 diagnostic test (under development).

Mr. Hartman also explained the plans to fund its R&D through a Section 501(c)(3) charitable organization, and/or through one or more joint ventures with established pharmaceutical companies to expedite Halberd's products to market.

Future plans include possible listing the company on foreign stock markets utilizing foreign subsidiaries, such as the one currently established in the UK.

You can view the entire interview video here.

If you would like to be added to our email subscriber list, click here and submit the form.

For more information please contact:
William A. Hartman
w.hartman@halberdcorporation.com
support@halberdcorporation.com
www.halberdcorporation.com
P. O. Box 25
Jackson Center, PA 16133
Twitter:@HalberdC

About Halberd Corporation.
Halberd Corporation. (OTC PINK:HALB), is a publicly-traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements. Halberd's Articles of Incorporation prohibit the company from issuance of convertible debt which would result in dilution. See the company's Articles of Incorporation here.

The company holds the exclusive rights to the COVID-19 extracorporeal treatment technology provisional patent applications: "Method for Treating and Curing Covid-19 Infection;" "Method for Treating COVID-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in COVID-19 Patients;" "Method for Treating and Curing COVID-19 Infection by Utilizing a Laser to Eradicate the Virus," and, "Nasal Spray To Prevent The Transmission Of Covid-19 Between Humans," "Nasal Spray to Prevent the Transmission of Covid-19," and "Method For Treating And Curing Covid-19 Infection By Utilizing Radiofrequency Extracorporeally To Eradicate The Virus." Halberd also holds the exclusive rights to the underlying granted U.S. Patent 9,216,386 and U.S. Patent 8,758,287.

Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). The Companies caution that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. The Companies undertake no obligation to revise these statements following the date of this news release.

Investor caution/added risk for investors in companies claiming involvement in COVID-19 initiatives –
On April 8, 2020, SEC Chairman Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.

The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatment or other strategies with regard to COVID-19.

The ultimate impact of the COVID-19 pandemic on the Company's operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.

We further caution investors that our primary focus and goal is to battle this pandemic for the good of the world. As such, it is possible that we may find it necessary to make disclosures which are consistent with that goal, but which may be adverse to the pecuniary interests of the Company and of its shareholders.

SOURCE: Halberd Corporation

ReleaseID: 618317

Advisory Board will be comprised of leading experts with diverse industry backgrounds supporting Carbon, Metals and Critical / Rare Earth

Randal Stephenson, a 3-year member of the Company's Board of Directors, will transition to assist and guide the Advisory Board as its inaugural member

FISHERS, IN / ACCESSWIRE / November 25, 2020 / American Resources Corporation (NASDAQ:AREC) ("American Resources" or the "Company"), a next generation and socially responsible supplier of raw materials to the new infrastructure marketplace, today announced the formation of a Strategic Advisory Board to aid in the advancement of its streamlined and efficient operations to economically deliver raw materials products through leveraging expertise of diverse industry backgrounds. The Strategic Advisory Board function is an informal committee that will assist the Company in its overall development and growth as well as strengthening its specific industry footprints. The goal of the Advisory Board is to provide relationship support, industry support and overall guidance and insights into American Resources' growth cycles of all three divisions.

Randal Stephenson, a valued member of the Company's Board of Directors, will transition as the founding member of the Strategic Advisory Board to lead and guide its development. As a member of the Company's Board for the last three years, Mr. Stephenson has played an instrumental role in helping guide American Resources through its public offering as well as capital raising the Company has achieved to-date.

Mark Jensen, Chairman and CEO of American Resources Corporation commented, "We are very excited to expand our capabilities, team and knowledge base with the creation of our Strategic Advisory Board. As a member of our Board over the course of the past three years, Randal played a hand in the growth of American Resources into a diversified producer of metallurgical carbon, metal recycling and critical / rare earth element development. He has proven to be a team player that has helped the Company through multiple acquisitions, financings and restructurings over the years, and we're excited to have someone of his caliber lead this important initiative. As we continue to speak with and seek additional members to bolster the knowledge and expertise of this Strategic Advisory Board, we look forward to building on the momentum and unlocking the potential for innovation and modernization of our industry."

American Resources will look to add individuals that can provide expertise and guidance as it advances at the holding company level as well as the three divisions described below:

American Carbon – A producer and processor of met carbon, PCI and stoker products to the new steel and infrastructure marketplace. The Company puts a large emphasis on efficiencies within its operations to ensure a low cost, high quality production base for many generations to come.

American Metals – An aggregator and processor of used steel primarily for the electric arc furnace marketplace. The Company is focused on establishing efficient supply chains to provide its customer base high volumes of processed steel, largely from sources that no longer fits a modern day economy, to be recycled into new steel for a variety of purposes.

American Rare Earth – An environmentally positive solution to the production, concentration and processing of critical and rare earth elements. The division is focused on restoring the rare earth supply chain back to the United States in the most cost effective, environmentally positive and socially conscious way. The division plans on producing and selling rare earth concentrate in the 2021 fiscal year with the goal of building the first processing facility in the eastern part of the U.S. to process to the element level.

American Resources Corporation is focused on running a streamlined and efficient operation to economically deliver raw materials products to meet its customers' demands. By operating with low or no legacy costs and having one of the largest and most innovative growth pipelines in the industry, American Resources Corporation works to maximize value for its investors while being able to scale its operations to meet the growth of the markets it serves.

About American Resources Corporation
American Resources Corporation is a supplier of high-quality raw materials to the rapidly growing global infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking. American Resources has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon deposits are concentrated.

American Resources has established a nimble, low-cost business model centered on growth, which provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure market while also continuing to acquire operations and significantly reduce their legacy industry risks. Its streamlined and efficient operations are able to maximize margins while reducing costs. For more information visit americanresourcescorp.com or connect with the Company on Facebook, Twitter, and LinkedIn.

Special Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the Company's actual results, performance, or achievements or industry results to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond American Resources Corporation's control. The words "believes", "may", "will", "should", "would", "could", "continue", "seeks", "anticipates", "plans", "expects", "intends", "estimates", or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Any forward-looking statements included in this press release are made only as of the date of this release. The Company does not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent events or circumstances. The Company cannot assure you that the projected results or events will be achieved.

PR Contact:
Precision Public Relations
Matt Sheldon
17-280-7329
matt@precisionpr.co

Investor Contact:
JTC Team, LLC
Jenene Thomas
833-475-8247
AREC@jtcir.com

Company Contact:
Mark LaVerghetta
317-855-9926 ext. 0
Vice President of Corporate Finance and Communications
investor@americanresourcescorp.com

SOURCE: American Resources Corporation

ReleaseID: 618292

Posts Record Quarterly EBITDA

TORONTO, ON / ACCESSWIRE / November 25, 2020 / Route1 Inc. (OTCQB:ROIUF)(TSXV:ROI) (the "Company" or "Route1"), an advanced North American provider of data-centric business empowerment solutions, today reported its financial results for the three- and nine-month periods ended September 30, 2020.

Statement of operations

In 000s of CAD dollars

 
 
Q32020
 
 
 
Q22020
 
 
 
Q12020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Revenue

Subscription and services

 
 
2,599
 
 
 
2,489
 
 
 
1,958
 
 
 
2,511
 
 
 
2,136
 
 
 
1,610
 

Devices and appliances

 
 
6,523
 
 
 
4,477
 
 
 
4,401
 
 
 
5,891
 
 
 
6,576
 
 
 
1,819
 

Other

 
 
25
 
 
 
3
 
 
 
4
 
 
 
1
 
 
 
2
 
 
 
1
 

Total revenue

 
 
9,147
 
 
 
6,969
 
 
 
6,363
 
 
 
8,403
 
 
 
8,714
 
 
 
3,430
 

Cost of revenue

 
 
6,134
 
 
 
4,188
 
 
 
3,997
 
 
 
5,653
 
 
 
5,953
 
 
 
1,672
 

Gross profit

 
 
3,013
 
 
 
2,781
 
 
 
2,366
 
 
 
2,750
 
 
 
2,761
 
 
 
1,758
 

Operating expenses

 
 
2,562
 
 
 
2,570
 
 
 
2,334
 
 
 
2,360
 
 
 
2,336
 
 
 
1,824
 

Operating profit (loss) 1

 
 
451
 
 
 
211
 
 
 
32
 
 
 
390
 
 
 
425
 
 
 
(66
)

Total other expenses 2, 3, 4

 
 
979
 
 
 
271
 
 
 
215
 
 
 
(120
)
 
 
424
 
 
 
487
 

Net income (loss)

 
 
(528
)
 
 
(60
)
 
 
(183
)
 
 
510
 
 
 
1
 
 
 
(553
)

1 Before stock-based compensation

2 Includes stock-based compensation, AirWatch litigation, gain on acquisition and foreign exchange

3 The reimbursements received from Bench Walk pursuant to its investment have been accounted for as a long-term non-monetary liability within the consolidated financial statements, not as a reduction to patent litigation expense. All such amounts are non-recourse to the Company. In connection with the terms of the agreement, the Company does not have a present obligation to pay any amounts until such time as the litigation has been settled or an event of default has occurred. In the event of an award or settlement of the litigation, the Company will be obligated to pay Bench Walk the greater of 10% of such award or settlement and $2,000,000 or $3,000,000 if the litigation proceeds to trial.

4 In the third quarter of 2020, the Company incurred Total Other Expenses of approximately $1.0 million. The largest components are: (a) gain on settlement of litigation of $0.2 million, (b) AirWatch litigation expenses and costs related to posting the fully cash-collateralized bond of $0.4, and (c) a reserve for $0.6 million related to the recovery of goods fraudulently taken from Route1. The Company was the victim of a fraud in the United States perpetrated by a group posing as legitimate customers with the goal of purchasing rugged devices. The Company has paid its vendor of record the full amount and has no further financial obligations. The Company has been in contact with its insurers but there is no assurance the Company will receive any amount of compensation.

Subscription and services revenue

in 000s of CAD dollars

 
 
Q32020
 
 
 
Q2
2020
 
 
 
Q12020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Application software

 
 
1,923
 
 
 
1,665
 
 
 
1,217
 
 
 
1,202
 
 
 
1,182
 
 
 
1,196
 

Technology as a service (TaaS)

 
 
241
 
 
 
315
 
 
 
321
 
 
 
353
 
 
 
322
 
 
 
311
 

Other services

 
 
435
 
 
 
509
 
 
 
420
 
 
 
956
 
 
 
632
 
 
 
103
 

Total

 
 
2,599
 
 
 
2,489
 
 
 
1,958
 
 
 
2,511
 
 
 
2,136
 
 
 
1,610
 

Adjusted EBITDA

in 000s of CAD dollars

 
 
Q32020
 
 
 
Q22020
 
 
 
Q1
2020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Gross Profit

 
 
3,013
 
 
 
2,781
 
 
 
2,366
 
 
 
2,750
 
 
 
2,761
 
 
 
1,758
 

Adjusted EBITDA 5

 
 
778
 
 
 
556
 
 
 
358
 
 
 
676
 
 
 
743
 
 
 
200
 

Amortization

 
 
327
 
 
 
346
 
 
 
326
 
 
 
286
 
 
 
318
 
 
 
266
 

Operating profit (loss)

 
 
451
 
 
 
211
 
 
 
32
 
 
 
390
 
 
 
425
 
 
 
(66
)

5 Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, stock-based compensation, patent litigation, restructuring and other costs. Adjusted EBITDA does not have any standardized meaning prescribed under IFRS and is therefore unlikely to be comparable to similar measures presented by other companies. Adjusted EBITDA allows Route1 to compare its operating performance over time on a consistent basis.

Balance sheet extracts

In 000s of CAD dollars

Sep 30

2020

Jun 30

2020

Mar 31

2020

Dec 31

2019

Sep 30

2019

Jun 30

2019

Cash

 
 
–
 
 
 
107
 
 
 
116
 
 
 
126
 
 
 
320
 
 
 
702
 

Total current assets 6

 
 
8,836
 
 
 
5,448
 
 
 
4,391
 
 
 
6,206
 
 
 
6,106
 
 
 
6,219
 

Total current liabilities

 
 
13,385
 
 
 
8,901
 
 
 
7,532
 
 
 
9,035
 
 
 
8,749
 
 
 
8,625
 

Net working capital

 
 
(4,549
)
 
 
(3,453
)
 
 
(3,141
)
 
 
(2,829
)
 
 
(2,643
)
 
 
(2,406
)

Net working capital adjusted for contract liability

 
 
490
 
 
 
800
 
 
 
(1,570
)
 
 
(1,078
)
 
 
(221
)
 
 
(149
)

Total assets

 
 
15,749
 
 
 
12,283
 
 
 
11,501
 
 
 
12,630
 
 
 
11,780
 
 
 
12,268
 

Bank debt and seller notes

 
 
2,609
 
 
 
1,193
 
 
 
2,461
 
 
 
2,415
 
 
 
2,294
 
 
 
1,862
 

Total shareholders' equity 3

 
 
37
 
 
 
778
 
 
 
950
 
 
 
980
 
 
 
473
 
 
 
854
 

6 Included as at September 30, 2020 is restricted cash of US$1,669,840 (CAD $2,226,065) that allowed Route1 to post a cash-collateralized bond with the court in the same amount in connection with the Company's appeal of the United States District Court for the District of Delaware partial granting of AirWatch's motion for attorney's fees in the matter of Route1 Inc. v. AirWatch, LLC.

Net cash flow

In 000s of CAD dollars

 
 
Q32020
 
 
 
Q2
2020
 
 
 
Q12020
 
 
 
Q42019
 
 
 
Q32019
 
 
 
Q22019
 

Cash generated in operating activities

 
 
1,523
 
 
 
1,773
 
 
 
472
 
 
 
64
 
 
 
20
 
 
 
965
 

Cash used in investing activities

 
 
(489
)
 
 
(240
)
 
 
(633
)
 
 
(174
)
 
 
(154
)
 
 
(1,303
)

Cash generated (used) in financing activities

 
 
1,092
 
 
 
(1,543
)
 
 
165
 
 
 
(28
)
 
 
(247
)
 
 
696
 

Net cash inflow (outflow)

 
 
2,126
 
 
 
(10
)
 
 
4
 
 
 
(138
)
 
 
(381
)
 
 
358
 

Business Update Conference Call and Webcast

The Company will hold a conference call and web cast to provide a business update on Wednesday, November 25, 2020 at 9:00 am eastern.

Participants should dial Toll-Free: 1-877-407-0781 or Toll/International: 1-201-689-8568 at least 10 minutes prior to the conference. For those unable to attend the call, a replay will be available on November 25, 2020 after 4 pm eastern at Toll-Free 1-877-481-4010 or Toll/International 1-919-882-2331, pass code #39006 until 10 am on Wednesday, December 2, 2020.

The webcast will be presented live at https://www.webcaster4.com/Webcast/Page/2167/39006.

About Route1 Inc.

Route1 Inc. is an advanced North American technology company that empowers their clients with data-centric solutions necessary to drive greater profitability, improve operational efficiency and gain sustainable competitive advantages, while always emphasizing a strong cybersecurity and information assurance posture. Route1 delivers exceptional client outcomes through real-time secure delivery of actionable intelligence to decision makers, whether it be in a manufacturing plant, in-theater or in a university parking lot. Route1 is listed on the OTCQB in the United States under the symbol ROIUF and in Canada on the TSX Venture Exchange under the symbol ROI. For more information, visit: www.route1.com.

For More Information, Contact:

Tony Busseri
President and Chief Executive Officer
+1 480 500-7030
tony.busseri@route1.com

This news release, required by applicable Canadian laws, does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

© 2020 Route1 Inc. All rights reserved. No part of this document may be reproduced, transmitted or otherwise used in whole or in part or by any means without prior written consent of Route1 Inc. See https://www.route1.com/terms-of-use/ for notice of Route1's intellectual property.

This news release may contain statements that are not current or historical factual statements that may constitute forward-looking statements or future oriented financial information. These statements are based on certain factors and assumptions, including, expectations regarding the success of the private placement and the terms on which the Company will raise funds, price and liquidity of the common shares, expected financial performance, expected subscribers and subscription-based revenue, business prospects, technological developments, development activities, the ability of the Company to obtain the supersedeas bond in order to appeal the decision to the United States Court of Appeals for the Federal Circuit, and like matters. While Route1 considers these factors and assumptions to be reasonable, based on information currently available, they may prove to be incorrect. These statements involve risks and uncertainties, including but not limited to the risk factors described in reporting documents filed by the Company. Actual results could differ materially from those projected as a result of these and other risks and should not be relied upon as a prediction of future events. The Company undertakes no obligation to update any forward-looking statement or future oriented financial information to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, except as required by law. Estimates used in this presentation are from Company sources. Past or forecasted performance is not a guarantee of future performance and readers should not rely on historical results or forward-looking statements or future oriented financial information as an assurance of future results.

SOURCE: Route1 Inc.

ReleaseID: 618285